Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Tokyo
- Most recent report
- 6-K, filed Aug 31, 2026
- Filings on record
- 701 filings
- On EDGAR
- CIK 1395064
- Filer status
- Large accelerated filer
Financials 8 of 350
- 6-K Report a foreign issuer made public elsewhere Aug 31, 2026
- 6-K Report a foreign issuer made public elsewhere Aug 6, 2026
- 6-K Report a foreign issuer made public elsewhere Jul 30, 2026
- 6-K Report a foreign issuer made public elsewhere Jul 9, 2026
- 6-K Report a foreign issuer made public elsewhere Jul 8, 2026
- 6-K Report a foreign issuer made public elsewhere Jun 29, 2026
- 6-K Report a foreign issuer made public elsewhere Jun 26, 2026
- 6-K Report a foreign issuer made public elsewhere Jun 24, 2026
Prospectuses and Registrations 8 of 19
- 424B2 Prospectus supplement for an offering Jun 27, 2025
- FWP Free writing prospectus Jun 27, 2025
- 424B5 Prospectus supplement for an offering Jun 26, 2025
- 424B2 Prospectus supplement for an offering Jun 28, 2024
- FWP Free writing prospectus Jun 28, 2024
- 424B5 Prospectus supplement for an offering Jun 27, 2024
- S-8 Registration statement for an employee plan Jun 28, 2023
- S-8 Registration statement for an employee plan Jun 29, 2022
Ownership 8 of 255
- 4 Insider reported a trade Sep 3, 2026
- 144 Notice of a proposed sale of restricted stock Sep 2, 2026
- 4 Insider reported a trade Aug 21, 2026
- 4 Insider reported a trade Aug 19, 2026
- 144 Notice of a proposed sale of restricted stock Aug 19, 2026
- 144 Notice of a proposed sale of restricted stock Aug 14, 2026
- 4 Insider reported a trade Aug 12, 2026
- 4 Insider reported a trade Aug 12, 2026
Other 8 of 77
- IRANNOTICE Notice of Iran-related activity Jun 17, 2026
- SD Conflict minerals disclosure May 22, 2026
- N-PX Record of how a fund voted its shares Aug 21, 2025
- F-3ASR Jun 25, 2025
- SD Conflict minerals disclosure May 12, 2025
- F-3ASR Jun 26, 2024
- SD Conflict minerals disclosure Apr 25, 2024
- SD Conflict minerals disclosure May 15, 2023
Everything here comes from Takeda Pharmaceutical Co Ltd's own filings on SEC EDGAR. The filing list is rechecked every hour.